- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03211559
Clinical Pilates and Aerobic Exercise in Patients With Ankylosing Spondylitis
Investigating the Effectiveness of Clinical Pilates Exercise When Applied Together With Aerobic Exercise in Patients With Ankylosing Spondylitis
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Famagusta, Cyprus, 99450
- Eastern Mediterranen University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Man and woman diagnosed with ankylosing spondylitis .
Exclusion Criteria:
- Any neurological or muscle diseases
- Inability to continuously attend the exercise program
- Visual, hearing or mental problems that could prevent communication
- Using mobility aids
- Pregnancy
- Malignity
- Having a surgery recently
- Doing exercise regularly in last 3 months.
- Having a cardiopulmonary problem which is not under control.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: AEROBİC EXERCİSE (walking on treadmill)
Patients walked on treadmill for 8 weeks, 3 days in a week,30-40 minutes each.
|
clinical pilates on mat
|
|
Experimental: Aerobic Exercise+Clinical Pilates
Patients walked on treamill for 8 weeks, 3 days in a week, 30-40 minutes each.
Additionally they did clinical pilates exercise for 8 weeks, 3 days in a week.
|
clinical pilates on mat
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Aerobic capacity will be detected with submaximal exercise testing (modified Bruce protocol).
Time Frame: Change from Baseline and at the end of 8 weeks
|
This test will be done while patients walking on TechnoGym Excitemed Treadmillde.
Heart rate will be followed with polars on the chest.
Medigraph V2000 device will be used to detect the oxygen amount consumed by the patient during the protocol.
|
Change from Baseline and at the end of 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Lateral spinal flexion distance was measured
Time Frame: At the begining and at the end of 8 weeks.
|
Lateral spinal flexion distance was measured with a measuring tape and recorded in centimeters.
|
At the begining and at the end of 8 weeks.
|
|
Lumbal flexion distance was measured
Time Frame: At the begining and at the end of 8 weeks.
|
Lumbal flexion distance was measured with a measuring tape and recorded in centimeters.
|
At the begining and at the end of 8 weeks.
|
|
Tragus to wall distance was measured
Time Frame: At the begining and at the end of 8 weeks.
|
Tragus to wall distance was measured with a measuring tape and recorded in centimeters.
|
At the begining and at the end of 8 weeks.
|
|
Intermalleoler distance was measured
Time Frame: At the begining and at the end of 8 weeks.
|
Intermalleoler distance was measured with a measuring tape and recorded in centimeters.
|
At the begining and at the end of 8 weeks.
|
|
servical rotation was measured
Time Frame: At the begining and at the end of 8 weeks.
|
servical rotation was measured with a goniometer and recorded in degrees.
|
At the begining and at the end of 8 weeks.
|
|
Spinal mobility of the chest will be measured with chest circumference test.
Time Frame: At the begining and at the end of 8 weeks.
|
Measuring tape will be placed at the 4th costa level.
the circumference during deep inspiration and deep expiration will be recorded in centimeters.
|
At the begining and at the end of 8 weeks.
|
|
Flexibility of the upper extremity will be measured with back scratch test.
Time Frame: At the begining and at the end of 8 weeks.
|
Patients will be asked to rotate their shoulder externally with palms facing their back.
Their hand fingers extend while trying to reach the lowest point the other arm internally rotates while trying to reach the highest point.
Patients are asked their fingertipsto be closer to each other.
If finger tips do not touch each other, the distance between them is recorded in cm assumed as a negative score, if the fingertips touch each other, then the scora is assumed as zero.
If they overlap, it is recorded in cm taking as positive score.
Three repetitions are performed consecutively and the best score was recorded.
|
At the begining and at the end of 8 weeks.
|
|
Static balance of the patients will be tested with single leg stance test.
Time Frame: At the beginning and at the end of 6 weeks
|
Performed with eyes open and arms on the hips, the participant must stand unassisted on one leg and is timed in seconds from the time one foot is flexed off the floor to the time when it touches the ground or the standing leg or an arm leaves the hips. The time passed on one leg will be recorded in seconds. Performed with eyes open and arms on the hips, the participant must stand unassisted on one leg and is timed in seconds from the time one foot is flexed off the floor to the time when it touches the ground or the standing leg or an arm leaves the hips. The time passed on one leg will be recorded in seconds. |
At the beginning and at the end of 6 weeks
|
|
Dynamic balance of the patients will be tested with functional reach test.
Time Frame: At the beginning and at the end of 6 weeks
|
The patient is instructed to next to, but not touching, a wall and position the arm that is closer to the wall at 90 degrees of shoulder flexion with a closed fist. The assessor records the starting position at the 3rd metacarpal head on the yardstick. Instruct the patient to "Reach as far as you can forward without taking a step." The location of the 3rd metacarpal is recorded. Scores are determined by assessing the difference between the start and end position is the reach distance, usually measured in inches. Three trials are done and the average of the last two is noted. |
At the beginning and at the end of 6 weeks
|
|
Strength and endurance of the lower extremities will be tested with Chair Sit and Stand Test
Time Frame: At the beginning and at the end of 6 weeks
|
In this test number of sitting and standing repetitions in sec.
will be recorded by the physiotherapist.
|
At the beginning and at the end of 6 weeks
|
|
The isometric strength of the back and lower extremity muscles will be measured with a dynamometer.
Time Frame: At the beginning and at the end of 6 weeks
|
Back-D (Digital Back Muscle) dynamometer will be used to measure the strength.
3 repetitions will be done and results will be recorded in kg.
|
At the beginning and at the end of 6 weeks
|
|
Functionality of the patients will be measured with Vath Ankylosing Spondylitis Functionality Index.
Time Frame: At the beginning and at the end of 6 weeks
|
In that questionnaire patients will be asked to mark the best functionality level in the past week on a 10 cm- visual analogue scale.
|
At the beginning and at the end of 6 weeks
|
|
Disease activity level be measured with Bath Ankylosing Spondylitis Disease Activity Index.
Time Frame: At the beginning and at the end of 6 weeks
|
The BASDAI consists of a one through 10 scale (one being no problem and 10 being the worst problem) which is used to answer 6 questions pertaining to the 5 major symptoms of AS: Fatigue Spinal pain Joint pain / swelling Areas of localized tenderness (also called enthesitis, or inflammation of tendons and ligaments) Morning stiffness duration Morning stiffness severity |
At the beginning and at the end of 6 weeks
|
|
Lung volumes and pulmonary functions will be tested with spirometric function tests.
Time Frame: At the beginning and at the end of 6 weeks
|
FUTUREMED Discovery Spirometry device will be used.
Mouth piece will be placed in patients mouth.
Patients will be asked to inhale and exhale 3 times.
Then they will be asked to take a deep breath and exhale forcibly as quick as possible.
3 repetitions will be done and the best score will be recorded.
|
At the beginning and at the end of 6 weeks
|
|
the strength of pulmonar muscles will be measured with Maximal Inspiratory Presssure and Maximal Expiratory Pressure inside the mouth.
Time Frame: At the beginning and at the end of 6 weeks
|
CAREFUSİON MicroRPM device will be used to measure the pressure inside the mouth during deep inspiration and deep expiration.
|
At the beginning and at the end of 6 weeks
|
|
Fatigue will be evaluated by the Multidimensional Fatigue Inventory (MFI)
Time Frame: At the beginning and at the end of 6 weeks
|
The MFI is a 20-item scale designed to evaluate five dimensions of fatigue: general fatigue, physical fatigue, reduced motivation, reduced activity, and mental fatigue.
It will be filled by the patient.
|
At the beginning and at the end of 6 weeks
|
|
Fatigue severity level of the patient will be evaluated by the Fatigue Severity Scale.
Time Frame: At the beginning and at the end of 6 weeks
|
The Fatigue Severity Scale is a 9-item scale which measures the severity of fatigue and its effect on a person's activities and lifestyle in patients with a variety of disorders.
İt will be filled by the patients.
|
At the beginning and at the end of 6 weeks
|
|
Sleep quality level of the patient will be evaluated by the Pitsburg Sleep Quality Index .
Time Frame: At the beginning and at the end of 6 weeks.
|
The Pittsburgh Sleep Quality Index (PSQI) is an effective instrument used to measure the quality and patterns of sleep in adults.
It differentiates "poor" from "good" sleep quality by measuring seven areas (components): subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medications, and daytime dysfunction over the last month.
Patient will be asked to fill this form.
|
At the beginning and at the end of 6 weeks.
|
|
Exercise capacity will be tested by the 6 minute walk test.
Time Frame: At the beginning and at the end of 6 weeks.
|
Walked distance during 6 minutes will be recorded in meters.
|
At the beginning and at the end of 6 weeks.
|
|
Quality of life of the patients will be determined with Ankylosing Spondylitis Quality of Life Scale.
Time Frame: At the beginning and at the end of 6 weeks.
|
The ASQoL provides a valuable tool for assessing the impact of interventions for AS and for evaluating models of service delivery.
It is well accepted by patients, taking about four minutes to complete, and has excellent scaling and psychometric properties.
Patients will be asked to fill the forms.
|
At the beginning and at the end of 6 weeks.
|
|
Change in the level of anxiety and depression assessed using Hospital Anxiety and Depression Scale at 6 weeks.
Time Frame: At the beginning and at the end of 6 weeks.
|
This scale was filled by the patients.
It has no special units.
The elevation of the total score indicates the increased anxiety and depression levels (score out of 42).
|
At the beginning and at the end of 6 weeks.
|
|
Change in the level of fear and avoidance associated with movement assessed using the Tampa Kinesiophobia Scale at 6 weeks.
Time Frame: At the beginning and at the end of 6 weeks.
|
This scale will be formed by the patients.
If an individual receives a high score, according to the scale, this result indicates a high level of kinesiophobia.
It has not a specific unit.
|
At the beginning and at the end of 6 weeks.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Oksuz, Eastern Mediterranean University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- GO 16/147
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Exercise
-
Centre Hospitalier de CorbieRecruitingExercise Training | Cardiac Rehabilitation | Exercise Intolerance | Exercise Intervention | Exercise Adaptations | HFrEF - Heart Failure With Reduced Ejection FractionFrance
-
Bitlis Eren UniversityCompletedExercise Physiology | Exercise ImmunologyTurkey (Türkiye)
-
Lindenwood UniversityIncrenovo, LLCRecruitingCognitive Function | Blood Flow | Nitric Oxide | Endurance Exercise | Exercise Performance | Exercise RecoveryUnited States
-
Hamza KucukCompletedExercise Training | Exercise PhysiologyTurkey (Türkiye)
-
Faculdade de Motricidade HumanaCompletedGreen Exercise | Indoor ExercisePortugal
-
Egas Moniz - Cooperativa de Ensino Superior, CRLCompletedAgeing | Aerobic Exercise | Resistance Exercise | Combined ExercisePortugal
-
Universidad Rey Juan CarlosCompletedEndurance Exercise | Running Performance | Exercise PhysiologySpain
-
Istanbul Sabahattin Zaim UniversityT.C. Dumlupınar ÜniversitesiCompletedExercise Ergogenics | Recovery Methods | Carnitine Ingestion | Exercise Fatigue | Exercise and RecoveryTurkey (Türkiye)
-
Hasan Kalyoncu UniversityNot yet recruiting
-
University of HawaiiKlein Buendel, Inc.CompletedMomZing Exercise Videos Online | Standard Exercise DVDUnited States
Clinical Trials on Exercise
-
National Institute of Neurological Disorders and...TerminatedTraumatic Brain InjuryUnited States
-
University of Texas, El PasoRecruitingKnee Osteoarthritis | Knee Pain Chronic | Central Pain SyndromeUnited States
-
Aksaray University Training and Research HospitalCompletedExercise Training | Lactate Blood Increase | Cognitive Functions | BDNFTurkey (Türkiye)
-
Bayero University Kano, NigeriaCompletedChronic Low Back PainNigeria
-
Toronto Rehabilitation InstituteCompletedAcute Myeloid LeukemiaCanada
-
University of Alabama at BirminghamCompletedCystic FibrosisUnited States
-
Center for Health, Exercise and Sport Sciences,...CompletedSedentary LifestyleSerbia
-
Heitor Moreno JuniorUnknown
-
Middle East Technical UniversityCompletedOsteoarthritis | Degenerative Lesion of Articular Cartilage of Knee | Articular Cartilage Disorder of KneeTurkey
-
University of LisbonFundação para a Ciência e a TecnologiaActive, not recruiting